Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 251

1.

Sex differences in neuropathy & neuropathic pain: A brief report from the Phase 2 Canadian Study of Longevity in Type 1 Diabetes.

Cardinez N, Lovblom LE, Orszag A, Bril V, Cherney DZ, Perkins BA.

J Diabetes Complications. 2019 Jun 20:107397. doi: 10.1016/j.jdiacomp.2019.06.002. [Epub ahead of print]

PMID:
31640908
2.

Analysis of Prevalence, Magnitude and Timing of the Dawn Phenomenon in Type 1 Diabetes: Descriptive Analysis of 2 Canadian Insulin Pump Trials in Adults and Adolescents.

Ostrovski I, Lovblom LE, Scarr D, Weisman A, Cardinez N, Orszag A, Falappa CM, D'Aoust É, Haidar A, Rabasa-Lhoret R, Legault L, Perkins BA.

Can J Diabetes. 2019 Aug 14. pii: S1499-2671(19)30593-3. doi: 10.1016/j.jcjd.2019.08.003. [Epub ahead of print]

PMID:
31630987
3.

Sex-Related Differences in Blood Glucose Responses to Resistance Exercise in Adults With Type 1 Diabetes: A Secondary Data Analysis.

Brockman NK, Sigal RJ, Kenny GP, Riddell MC, Perkins BA, Yardley JE.

Can J Diabetes. 2019 Aug 22. pii: S1499-2671(19)30596-9. doi: 10.1016/j.jcjd.2019.08.006. [Epub ahead of print]

PMID:
31623995
4.

Randomized, controlled crossover study of IVIg for demyelinating polyneuropathy and diabetes.

Breiner A, Barnett Tapia C, Lovblom LE, Perkins BA, Katzberg HD, Bril V.

Neurol Neuroimmunol Neuroinflamm. 2019 Jul 10;6(5). pii: e586. doi: 10.1212/NXI.0000000000000586. Print 2019 Sep.

5.

Graves' Disease After Chronic Hypothyroidism in Type 1 Diabetes.

Cardinez N, Opsteen C, Perkins BA.

Can J Diabetes. 2019 Jun 13. pii: S1499-2671(19)30181-9. doi: 10.1016/j.jcjd.2019.05.012. [Epub ahead of print] No abstract available.

PMID:
31445960
6.

Estimating GFR by Serum Creatinine, Cystatin C, and β2-Microglobulin in Older Adults: Results From the Canadian Study of Longevity in Type 1 Diabetes.

Scarr D, Bjornstad P, Lovblom LE, Lovshin JA, Boulet G, Lytvyn Y, Farooqi MA, Lai V, Orszag A, Weisman A, Keenan HA, Brent MH, Paul N, Bril V, Cherney DZI, Perkins BA.

Kidney Int Rep. 2019 Feb 21;4(6):786-796. doi: 10.1016/j.ekir.2019.02.010. eCollection 2019 Jun.

7.

Preventing Early Renal Loss in Diabetes (PERL) Study: A Randomized Double-Blinded Trial of Allopurinol-Rationale, Design, and Baseline Data.

Afkarian M, Polsky S, Parsa A, Aronson R, Caramori ML, Cherney DZ, Crandall JP, de Boer IH, Elliott TG, Galecki AT, Goldfine AB, Haw JS, Hirsch IB, Karger AB, Lingvay I, Maahs DM, McGill JB, Molitch ME, Perkins BA, Pop-Busui R, Pragnell M, Rosas SE, Rossing P, Senior P, Sigal RJ, Spino C, Tuttle KR, Umpierrez GE, Wallia A, Weinstock RS, Wu C, Mauer M, Doria A; PERL Study Group.

Diabetes Care. 2019 Aug;42(8):1454-1463. doi: 10.2337/dc19-0342. Epub 2019 Jun 11.

PMID:
31186299
8.

Elevated plasma cyclic guanosine monophosphate may explain greater efferent arteriolar tone in adults with longstanding type 1 diabetes: A brief report.

Bjornstad P, Lovshin JA, Lytvyn Y, Lovblom LE, Scarr D, Boulet G, Farooqi MA, Orszag A, Bai JW, Weisman A, Keenan HA, Brent MH, Paul N, Bril V, Perkins BA, Cherney DZI.

J Diabetes Complications. 2019 Aug;33(8):547-549. doi: 10.1016/j.jdiacomp.2019.05.007. Epub 2019 May 17.

PMID:
31186164
9.

Exploring Patient Preferences for Adjunct-to-Insulin Therapy in Type 1 Diabetes.

Perkins BA, Rosenstock J, Skyler JS, Laffel LM, Cherney DZ, Mathieu C, Pang C, Wood R, Kinduryte O, George JT, Marquard J, Soleymanlou N.

Diabetes Care. 2019 Sep;42(9):1716-1723. doi: 10.2337/dc19-0548. Epub 2019 Jun 8.

PMID:
31177179
10.

Risk factors for diabetic kidney disease in adults with longstanding type 1 diabetes: results from the Canadian Study of Longevity in Diabetes.

Sekercioglu N, Lovblom LE, Bjornstad P, Lovshin JA, Lytvyn Y, Boulet G, Farooqi MA, Orszag A, Lai V, Tse J, Cham L, Keenan HA, Brent MH, Paul N, Bril V, Perkins BA, Cherney DZI.

Ren Fail. 2019 Nov;41(1):427-433. doi: 10.1080/0886022X.2019.1614057.

11.

A Genetic Locus on Chromosome 2q24 Predicting Peripheral Neuropathy Risk in Type 2 Diabetes: Results From the ACCORD and BARI 2D Studies.

Tang Y, Lenzini PA, Pop-Busui R, Ray PR, Campbell H, Perkins BA, Callaghan B, Wagner MJ, Motsinger-Reif AA, Buse JB, Price TJ, Mychaleckyj JC, Cresci S, Shah H, Doria A.

Diabetes. 2019 Aug;68(8):1649-1662. doi: 10.2337/db19-0109. Epub 2019 May 24.

PMID:
31127053
12.

Authors' reply to: "The role of long-term effects of allopurinol on cardiovascular outcomes and all-cause mortality in diabetes".

Weisman A, Tomlinson GA, Lipscombe LL, Perkins BA, Hawker GA.

Diabetes Obes Metab. 2019 Sep;21(9):2181-2182. doi: 10.1111/dom.13789. Epub 2019 Jun 17. No abstract available.

PMID:
31111997
13.

Bone mineral density in patients with longstanding type 1 diabetes: Results from the Canadian Study of Longevity in Type 1 Diabetes.

Alhuzaim ON, Lewis EJH, Lovblom LE, Cardinez M, Scarr D, Boulet G, Weisman A, Lovshin JA, Lytvyn Y, Keenan HA, Brent MH, Paul N, Bril V, Cherney DZI, Perkins BA.

J Diabetes Complications. 2019 Nov;33(11):107324. doi: 10.1016/j.jdiacomp.2018.12.009. Epub 2018 Dec 22.

PMID:
31003922
14.

Molecular regulation of the renin-angiotensin system by sodium-glucose cotransporter 2 inhibition in type 1 diabetes mellitus.

Kopecky C, Lytvyn Y, Domenig O, Antlanger M, Kovarik JJ, Kaltenecker CC, Poglitsch M, Perkins BA, Rye KA, Cherney DZI, Säemann MD.

Diabetologia. 2019 Jun;62(6):1090-1093. doi: 10.1007/s00125-019-4871-8. Epub 2019 Apr 11. No abstract available.

PMID:
30976852
15.

Uric Acid Levels Correlate with Sensory Nerve Function in Healthy Subjects.

Abraham A, Katzberg HD, Lovblom LE, Perkins BA, Bril V.

Can J Neurol Sci. 2019 May;46(3):337-341. doi: 10.1017/cjn.2019.9. Epub 2019 Mar 18.

PMID:
30880660
16.

Risk Factors for Kidney Disease in Type 1 Diabetes.

Perkins BA, Bebu I, de Boer IH, Molitch M, Tamborlane W, Lorenzi G, Herman W, White NH, Pop-Busui R, Paterson AD, Orchard T, Cowie C, Lachin JM; Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group.

Diabetes Care. 2019 May;42(5):883-890. doi: 10.2337/dc18-2062. Epub 2019 Mar 4.

PMID:
30833370
17.

Renal Hemodynamic Function and RAAS Activation Over the Natural History of Type 1 Diabetes.

Lytvyn Y, Bjornstad P, Lovshin JA, Boulet G, Farooqi MA, Lai V, Tse J, Cham L, Lovblom LE, Weisman A, Keenan HA, Brent MH, Paul N, Bril V, Advani A, Sochett E, Perkins BA, Cherney DZI.

Am J Kidney Dis. 2019 Jun;73(6):786-796. doi: 10.1053/j.ajkd.2018.12.034. Epub 2019 Feb 22.

PMID:
30799029
18.

Association between uric acid, renal haemodynamics and arterial stiffness over the natural history of type 1 diabetes.

Lytvyn Y, Bjornstad P, Lovshin JA, Singh SK, Boulet G, Farooqi MA, Lai V, Tse J, Cham L, Lovblom LE, Weisman A, Keenan HA, Brent MH, Paul N, Bril V, Advani A, Sochett E, Perkins BA, Cherney DZI.

Diabetes Obes Metab. 2019 Jun;21(6):1388-1398. doi: 10.1111/dom.13665. Epub 2019 Mar 28.

PMID:
30761725
19.

Association between allopurinol and cardiovascular outcomes and all-cause mortality in diabetes: A retrospective, population-based cohort study.

Weisman A, Tomlinson GA, Lipscombe LL, Perkins BA, Hawker GA.

Diabetes Obes Metab. 2019 Jun;21(6):1322-1329. doi: 10.1111/dom.13656. Epub 2019 Mar 25.

PMID:
30734980
20.

Retinopathy and RAAS Activation: Results From the Canadian Study of Longevity in Type 1 Diabetes.

Lovshin JA, Lytvyn Y, Lovblom LE, Katz A, Boulet G, Bjornstad P, Lai V, Cham L, Tse J, Orszag A, Keenan HA, Paul N, Bril V, Wong DT, McReelis KD, Brent MH, Perkins BA, Cherney DZI.

Diabetes Care. 2019 Feb;42(2):273-280. doi: 10.2337/dc18-1809. Epub 2018 Dec 6.

PMID:
30523033
21.

The relationships between markers of tubular injury and intrarenal haemodynamic function in adults with and without type 1 diabetes: Results from the Canadian Study of Longevity in Type 1 Diabetes.

Bjornstad P, Singh SK, Snell-Bergeon JK, Lovshin JA, Lytvyn Y, Lovblom LE, Rewers MJ, Boulet G, Lai V, Tse J, Cham L, Orszag A, Weisman A, Keenan HA, Brent MH, Paul N, Bril V, Perkins BA, Cherney DZI.

Diabetes Obes Metab. 2019 Mar;21(3):575-583. doi: 10.1111/dom.13556. Epub 2018 Nov 11.

PMID:
30311395
22.

Empagliflozin as Adjunctive to Insulin Therapy in Type 1 Diabetes: The EASE Trials.

Rosenstock J, Marquard J, Laffel LM, Neubacher D, Kaspers S, Cherney DZ, Zinman B, Skyler JS, George J, Soleymanlou N, Perkins BA.

Diabetes Care. 2018 Dec;41(12):2560-2569. doi: 10.2337/dc18-1749. Epub 2018 Oct 4.

PMID:
30287422
23.

Atherosclerosis and Microvascular Complications: Results From the Canadian Study of Longevity in Type 1 Diabetes.

Lovshin JA, Bjornstad P, Lovblom LE, Bai JW, Lytvyn Y, Boulet G, Farooqi MA, Santiago S, Orszag A, Scarr D, Weisman A, Keenan HA, Brent MH, Paul N, Bril V, Perkins BA, Cherney DZI.

Diabetes Care. 2018 Dec;41(12):2570-2578. doi: 10.2337/dc18-1236. Epub 2018 Oct 1.

PMID:
30275283
24.

Sex differences in neuropathic pain in longstanding diabetes: Results from the Canadian Study of Longevity in Type 1 Diabetes.

Cardinez N, Lovblom LE, Bai JW, Lewis E, Abraham A, Scarr D, Lovshin JA, Lytvyn Y, Boulet G, Farooqi MA, Orszag A, Weisman A, Keenan HA, Brent MH, Paul N, Bril V, Cherney DZ, Perkins BA.

J Diabetes Complications. 2018 Jul;32(7):660-664. doi: 10.1016/j.jdiacomp.2018.05.001. Epub 2018 May 5.

PMID:
29929836
25.

Corneal confocal microscopy for identification of diabetic sensorimotor polyneuropathy: a pooled multinational consortium study.

Perkins BA, Lovblom LE, Bril V, Scarr D, Ostrovski I, Orszag A, Edwards K, Pritchard N, Russell A, Dehghani C, Pacaud D, Romanchuk K, Mah JK, Jeziorska M, Marshall A, Shtein RM, Pop-Busui R, Lentz SI, Boulton AJM, Tavakoli M, Efron N, Malik RA.

Diabetologia. 2018 Aug;61(8):1856-1861. doi: 10.1007/s00125-018-4653-8. Epub 2018 Jun 4.

26.

Validity of a point-of-care nerve conduction device for polyneuropathy identification in older adults with diabetes: Results from the Canadian Study of Longevity in Type 1 Diabetes.

Scarr D, Lovblom LE, Cardinez N, Orszag A, Farooqi MA, Boulet G, Weisman A, Lovshin JA, Ngo M, Paul N, Keenan HA, Brent MH, Cherney DZ, Bril V, Perkins BA.

PLoS One. 2018 Apr 30;13(4):e0196647. doi: 10.1371/journal.pone.0196647. eCollection 2018.

27.

Neuropathy.

Diabetes Canada Clinical Practice Guidelines Expert Committee, Bril V, Breiner A, Perkins BA, Zochodne D.

Can J Diabetes. 2018 Apr;42 Suppl 1:S217-S221. doi: 10.1016/j.jcjd.2017.10.028. No abstract available.

PMID:
29650100
28.

Sex differences in neuropathic pain intensity in diabetes.

Abraham A, Barnett C, Katzberg HD, Lovblom LE, Perkins BA, Bril V.

J Neurol Sci. 2018 May 15;388:103-106. doi: 10.1016/j.jns.2018.03.008. Epub 2018 Mar 6.

PMID:
29627001
29.

Precision medicine screening using whole-genome sequencing and advanced imaging to identify disease risk in adults.

Perkins BA, Caskey CT, Brar P, Dec E, Karow DS, Kahn AM, Hou YC, Shah N, Boeldt D, Coughlin E, Hands G, Lavrenko V, Yu J, Procko A, Appis J, Dale AM, Guo L, Jönsson TJ, Wittmann BM, Bartha I, Ramakrishnan S, Bernal A, Brewer JB, Brewerton S, Biggs WH, Turpaz Y, Venter JC.

Proc Natl Acad Sci U S A. 2018 Apr 3;115(14):3686-3691. doi: 10.1073/pnas.1706096114. Epub 2018 Mar 19.

30.

Adiposity Impacts Intrarenal Hemodynamic Function in Adults With Long-standing Type 1 Diabetes With and Without Diabetic Nephropathy: Results From the Canadian Study of Longevity in Type 1 Diabetes.

Bjornstad P, Lovshin JA, Lytvyn Y, Boulet G, Lovblom LE, Alhuzaim ON, Farooqi MA, Lai V, Tse J, Cham L, Orszag A, Scarr D, Weisman A, Keenan HA, Brent MH, Paul N, Bril V, Perkins BA, Cherney DZI.

Diabetes Care. 2018 Apr;41(4):831-839. doi: 10.2337/dc17-2475. Epub 2018 Feb 2.

31.

Laboratory Abnormalities in Polyneuropathy and Electrophysiological Correlations.

Abraham A, Breiner A, Barnett C, Katzberg HD, Ngo M, Lovblom LE, Perkins BA, Bril V.

Can J Neurol Sci. 2018 May;45(3):346-349. doi: 10.1017/cjn.2017.298. Epub 2018 Feb 13.

PMID:
29433597
32.

Nerve function varies with hemoglobin A1c in controls and type 2 diabetes.

Abraham A, Barnett C, Katzberg HD, Lovblom LE, Perkins BA, Bril V.

J Diabetes Complications. 2018 Apr;32(4):424-428. doi: 10.1016/j.jdiacomp.2017.12.007. Epub 2017 Dec 21.

PMID:
29422233
33.

Renin-angiotensin-aldosterone system activation in long-standing type 1 diabetes.

Lovshin JA, Boulet G, Lytvyn Y, Lovblom LE, Bjornstad P, Farooqi MA, Lai V, Cham L, Tse J, Orszag A, Scarr D, Weisman A, Keenan HA, Brent MH, Paul N, Bril V, Perkins BA, Cherney DZ.

JCI Insight. 2018 Jan 11;3(1). pii: 96968. doi: 10.1172/jci.insight.96968. eCollection 2018 Jan 11.

34.

High frequency of MGUS in DSP.

Abraham A, Barnett C, Katzberg HD, Lovblom LE, Perkins BA, Bril V.

Muscle Nerve. 2018 Jun;57(6):1018-1021. doi: 10.1002/mus.26054. Epub 2018 Feb 2.

PMID:
29314079
35.

Toronto Clinical Neuropathy Score is valid for a wide spectrum of polyneuropathies.

Abraham A, Barnett C, Katzberg HD, Lovblom LE, Perkins BA, Bril V.

Eur J Neurol. 2018 Mar;25(3):484-490. doi: 10.1111/ene.13533. Epub 2017 Dec 26.

PMID:
29194856
36.

Biomarkers of tubulointerstitial damage and function in type 1 diabetes.

de Boer IH, Gao X, Bebu I, Hoofnagle AN, Lachin JM, Paterson A, Perkins BA, Saenger AK, Steffes MW, Zinman B, Molitch ME.

BMJ Open Diabetes Res Care. 2017 Nov 14;5(1):e000461. doi: 10.1136/bmjdrc-2017-000461. eCollection 2017.

37.

Cramps frequency and severity are correlated with small and large nerve fiber measures in type 1 diabetes.

Abraham A, Barnett C, Lovblom LE, Perkins BA, Bril V, Katzberg HD.

Clin Neurophysiol. 2018 Jan;129(1):122-126. doi: 10.1016/j.clinph.2017.10.029. Epub 2017 Nov 11.

PMID:
29175104
38.

Diabetes Care Disparities in Long-standing Type 1 Diabetes in Canada and the U.S.: A Cross-sectional Comparison.

Weisman A, Lovblom LE, Keenan HA, Tinsley LJ, D'Eon S, Boulet G, Farooqi MA, Lovshin JA, Orszag A, Lytvyn Y, Brent MH, Paul N, Bril V, Cherney DZ, Perkins BA.

Diabetes Care. 2018 Jan;41(1):88-95. doi: 10.2337/dc17-1074. Epub 2017 Nov 8.

39.

The effect of sodium/glucose cotransporter 2 (SGLT2) inhibition on the urinary proteome.

Cherney D, Perkins BA, Lytvyn Y, Heerspink H, Rodríguez-Ortiz ME, Mischak H.

PLoS One. 2017 Oct 30;12(10):e0186910. doi: 10.1371/journal.pone.0186910. eCollection 2017.

40.

Lower corneal nerve fibre length identifies diabetic neuropathy in older adults with diabetes: results from the Canadian Study of Longevity in Type 1 Diabetes.

Scarr D, Lovblom LE, Lovshin JA, Boulet G, Farooqi MA, Orszag A, Weisman A, Cardinez N, Lytvyn Y, Ngo M, Keenan HA, Brent MH, Paul N, Bril V, Cherney DZI, Perkins BA.

Diabetologia. 2017 Dec;60(12):2529-2531. doi: 10.1007/s00125-017-4439-4. Epub 2017 Oct 3. No abstract available.

PMID:
28971222
41.

Meta-analysis of artificial pancreas trials: methodological considerations - Authors' reply.

Weisman A, Kramer CK, Perkins BA.

Lancet Diabetes Endocrinol. 2017 Sep;5(9):685-686. doi: 10.1016/S2213-8587(17)30237-1. No abstract available.

PMID:
28842160
42.

Uric acid levels correlate with the severity of diabetic sensorimotor polyneuropathy.

Abraham A, Breiner A, Barnett C, Katzberg HD, Lovblom LE, Perkins BA, Bril V.

J Neurol Sci. 2017 Aug 15;379:94-98. doi: 10.1016/j.jns.2017.05.053. Epub 2017 May 25.

PMID:
28716288
43.

Neuropathy and presence of emotional distress and depression in longstanding diabetes: Results from the Canadian study of longevity in type 1 diabetes.

Bai JW, Lovblom LE, Cardinez M, Weisman A, Farooqi MA, Halpern EM, Boulet G, Eldelekli D, Lovshin JA, Lytvyn Y, Keenan HA, Brent MH, Paul N, Bril V, Cherney DZI, Perkins BA.

J Diabetes Complications. 2017 Aug;31(8):1318-1324. doi: 10.1016/j.jdiacomp.2017.05.002. Epub 2017 May 10.

PMID:
28599823
44.

Effect of artificial pancreas systems on glycaemic control in patients with type 1 diabetes: a systematic review and meta-analysis of outpatient randomised controlled trials.

Weisman A, Bai JW, Cardinez M, Kramer CK, Perkins BA.

Lancet Diabetes Endocrinol. 2017 Jul;5(7):501-512. doi: 10.1016/S2213-8587(17)30167-5. Epub 2017 May 19. Review.

PMID:
28533136
45.

Effect of omega-3 supplementation on neuropathy in type 1 diabetes: A 12-month pilot trial.

Lewis EJH, Perkins BA, Lovblom LE, Bazinet RP, Wolever TMS, Bril V.

Neurology. 2017 Jun 13;88(24):2294-2301. doi: 10.1212/WNL.0000000000004033. Epub 2017 May 17.

46.

Renal and Vascular Effects of Uric Acid Lowering in Normouricemic Patients With Uncomplicated Type 1 Diabetes.

Lytvyn Y, Har R, Locke A, Lai V, Fong D, Advani A, Perkins BA, Cherney DZI.

Diabetes. 2017 Jul;66(7):1939-1949. doi: 10.2337/db17-0168. Epub 2017 Apr 13.

47.

Urinary adenosine excretion in type 1 diabetes.

Rajasekeran H, Lytvyn Y, Bozovic A, Lovshin JA, Diamandis E, Cattran D, Husain M, Perkins BA, Advani A, Reich HN, Kulasingam V, Cherney DZI.

Am J Physiol Renal Physiol. 2017 Aug 1;313(2):F184-F191. doi: 10.1152/ajprenal.00043.2017. Epub 2017 Apr 5.

48.

Erratum to: Characterisation of glomerular haemodynamic responses to SGLT2 inhibition in patients with type 1 diabetes and renal hyperfiltration.

Škrtić M, Yang GK, Perkins BA, Soleymanlou N, Lytvyn Y, von Eynatten M, Woerle HJ, Johansen OE, Broedl UC, Hach T, Silverman M, Cherney DZI.

Diabetologia. 2017 Jun;60(6):1159-1160. doi: 10.1007/s00125-017-4241-3. No abstract available.

PMID:
28374067
49.

Agreement between automated and manual quantification of corneal nerve fiber length: Implications for diabetic neuropathy research.

Scarr D, Lovblom LE, Ostrovski I, Kelly D, Wu T, Farooqi MA, Halpern EM, Ngo M, Ng E, Orszag A, Bril V, Perkins BA.

J Diabetes Complications. 2017 Jun;31(6):1066-1073. doi: 10.1016/j.jdiacomp.2016.07.024. Epub 2016 Jul 26.

PMID:
28347694
50.

Whole-genome sequencing identifies common-to-rare variants associated with human blood metabolites.

Long T, Hicks M, Yu HC, Biggs WH, Kirkness EF, Menni C, Zierer J, Small KS, Mangino M, Messier H, Brewerton S, Turpaz Y, Perkins BA, Evans AM, Miller LA, Guo L, Caskey CT, Schork NJ, Garner C, Spector TD, Venter JC, Telenti A.

Nat Genet. 2017 Apr;49(4):568-578. doi: 10.1038/ng.3809. Epub 2017 Mar 6.

PMID:
28263315

Supplemental Content

Loading ...
Support Center